Pfizer Inc. has acquired Alacer Corp., maker and distributor of the Emergen-C line of vitamin C products. Terms of the purchase were not disclosed.


Pfizer Inc., Alacer Corp., Emergen-C, vitamin C, Paul Sturman, president of Pfizer Consumer Healthcare








































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks

Pfizer buys Alacer

February 28th, 2012

NEW YORK – Pfizer Inc. has acquired Alacer Corp., maker and distributor of the Emergen-C line of vitamin C products. Terms of the purchase were not disclosed.

"We are very pleased that the Emergen-C family of products will become part of Pfizer’s portfolio," said Paul Sturman, president of Pfizer Consumer Healthcare. "We expect that our global network and deep expertise in dietary supplements, combined with our desire to provide consumers with high-quality products will make Emergen-C more accessible than it has ever been before. Emergen-C products add to and greatly complement our market-leading dietary supplement portfolio."
 

More Supplier News Breaks >>
Advertisement